US 8846896
Methods of preparing substituted nucleotide analogs
granted A61PA61P31/12
Quick answer
US patent 8846896 (Methods of preparing substituted nucleotide analogs) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P31/12